Neuropace Inc. Company Profile
NASDAQ: NPCEHealth CareMedical/Dental InstrumentsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 12.39 0.00%
Neuropace at a glance
Neuropace Inc. (NASDAQ: NPCE) is a Medical/Dental Instruments company in the Health Care sector headquartered in Mountain View, CA. Neuropace is led by Mr. Joel D. Becker and employs about 220 people. The company's shares have traded publicly since 2021.
At a market capitalization of $434.9 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001528287, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Neuropace do?
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Business description based on the company's public filings.
Company information
- Legal name
- Neuropace Inc.
- Ticker
- NASDAQ: NPCE
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Joel D. Becker
- Employees
- 220
- Headquarters
- 455 North Bernardo Avenue, Mountain View, CA, United States
- Phone
- 650 237 2700
- Website
- neuropace.com
- IPO year
- 2021
- Market cap
- $434.89M
- SEC CIK
- 0001528287
Companies similar to Neuropace
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RCELAvita Medical Inc. | 13.33 | +2.15% | $412.25M | vs NPCE |
| CERSCerus Corporation | 2.28 | -0.44% | $459.48M | vs NPCE |
| BWAYBrainsWay Ltd. ADR | 11.47 | -1.29% | $461.70M | vs NPCE |
| SGHTSight Sciences Inc. | 8.47 | 0.00% | $466.60M | vs NPCE |
| ANGOAngioDynamics Inc. | 11.23 | -20.86% | $472.27M | vs NPCE |
| SENSSenseonics Holdings Inc. | 9.02 | -1.53% | $476.92M | vs NPCE |
| CARLCarlsmed Inc. | 14.05 | -2.29% | $383.60M | vs NPCE |
| SIShoulder Innovations Inc. | 17.89 | -4.38% | $372.45M | vs NPCE |